Skip to main navigation Skip to search Skip to main content

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma

  • Howard Colman
  • , Giuseppe Lombardi
  • , Eric T. Wong
  • , Tobias Walbert
  • , Marica Eoli
  • , Andrew B. Lassman
  • , David M. Peereboom
  • , Sani H. Kizilbash
  • , Carlos Kamiya-Matsuoka
  • , Marshall W. Pitz
  • , Roy E. Strowd
  • , Annick Desjardins
  • , Priya Kumthekar
  • , Warren Mason
  • , Alessia Pellerino
  • , Riccardo Soffietti
  • , Nicholas Butowski
  • , Peter A. Forsyth
  • , Mohamed A. Hamza
  • , Peter Hau
    • Enrico Lallana, Burt Nabors, David Piccioni, Erik J. Uhlmann, Liam C. Welsh, Patrick Y. Wen, Jorg Dietrich, Chao Wang, Victor A. Levin

Research output: Contribution to journal › Article › peer-review

4   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science